drugset / Trial / NCT03604328
Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma
NaSingle-groupOpen-labelTreatment
Summary
A single centre, open label, study to assess the safety, tolerability and biodegradation of PA5108 ocular implant in adults who have Open Angle Glaucoma (Primary or Secondary).
Timeline
- Start
- 2018-07-24
- Primary completion
- 2020-06-15
- Completion
- 2020-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PA5108 | Unknown | — | Other |